Nebula Research & Development LLC Purchases 1,707 Shares of Transcat, Inc. (NASDAQ:TRNS)

Nebula Research & Development LLC boosted its position in Transcat, Inc. (NASDAQ:TRNSFree Report) by 31.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 7,103 shares of the scientific and technical instruments company’s stock after acquiring an additional 1,707 shares during the quarter. Nebula Research & Development LLC’s holdings in Transcat were worth $751,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Jones Financial Companies Lllp increased its holdings in Transcat by 686.7% during the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company’s stock worth $37,000 after purchasing an additional 309 shares in the last quarter. Morgan Dempsey Capital Management LLC bought a new stake in Transcat during the 4th quarter worth approximately $143,000. SG Americas Securities LLC bought a new stake in Transcat during the 4th quarter worth approximately $182,000. KLP Kapitalforvaltning AS bought a new stake in Transcat during the 4th quarter worth approximately $190,000. Finally, XTX Topco Ltd bought a new stake in Transcat during the 4th quarter worth approximately $326,000. 98.34% of the stock is owned by institutional investors.

Insider Activity at Transcat

In other news, Director Craig D. Cairns acquired 1,200 shares of the company’s stock in a transaction that occurred on Friday, January 31st. The shares were acquired at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the completion of the purchase, the director now owns 1,910 shares in the company, valued at approximately $147,108.20. This trade represents a 169.01 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 2.30% of the stock is owned by company insiders.

Transcat Price Performance

Shares of NASDAQ TRNS opened at $85.13 on Monday. Transcat, Inc. has a twelve month low of $67.56 and a twelve month high of $147.12. The stock’s 50 day moving average price is $77.14 and its 200-day moving average price is $94.21. The company has a market capitalization of $792.48 million, a PE ratio of 46.02 and a beta of 0.67. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14.

Transcat (NASDAQ:TRNSGet Free Report) last announced its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same period in the prior year, the firm posted $0.56 EPS. On average, equities analysts anticipate that Transcat, Inc. will post 2.3 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. HC Wainwright decreased their price objective on Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a report on Wednesday, January 29th. Oppenheimer lowered Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 29th. StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a report on Wednesday, February 5th. Finally, Northland Securities restated a “market perform” rating and issued a $85.00 target price (down previously from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $111.50.

Check Out Our Latest Research Report on TRNS

About Transcat

(Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

See Also

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNSFree Report).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.